Scandinavian Journal of Clinical and Laboratory Investigation
ISSN: 0036-5513 (Print) 1502-7686 (Online) Journal homepage: http://www.tandfonline.com/loi/iclb20
Plasma homocysteine in women on oral oestrogen-containing contraceptives and in men with oestrogen-treated prostatic carcinoma L. Brattström, B. Israelsson, A. Olsson, A. Andersson & B. Hultberg To cite this article: L. Brattström, B. Israelsson, A. Olsson, A. Andersson & B. Hultberg (1992) Plasma homocysteine in women on oral oestrogen-containing contraceptives and in men with oestrogen-treated prostatic carcinoma, Scandinavian Journal of Clinical and Laboratory Investigation, 52:4, 283-287, DOI: 10.1080/00365519209088360 To link to this article: http://dx.doi.org/10.1080/00365519209088360
Published online: 29 Mar 2011.
Submit your article to this journal
Article views: 10
View related articles
Citing articles: 3 View citing articles
Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=iclb20 Download by: [RMIT University Library]
Date: 15 March 2016, At: 19:21
Scand J Clin Lab Invest 1902; 52: 283-287
Plasma homocysteine in women on oral oestrogen-containing contraceptives and in men with oestrogen-treated prostatic carcinoma L . BRATTSTROM,* B. ISRAELSSON,t A. OLSSON,$ A . ANDERSSONB & B. HULTBERGli
Downloaded by [RMIT University Library] at 19:21 15 March 2016
University of Lund, Departments of 'Neurology, tUrology, and $Clinical Chemistry4, University Hospital, Lund, and the ?Department of Medicine, Malmo General Hospital, Sweden.
Brattstrom L, lsraelsson B, Olsson A, Anderson A, Hultberg B. Plasma homocysteine in women on oral oestrogen-containing contraceptives and in men with oestrogen-treated prostatic carcinoma. Scand J Clin Lab Invest 1992; 52: 283-287. The mechanism by which oral oestrogen-containing contraceptives in women and oestrogen treatment of prostatic carcinoma in men increases the risk of vascular disease is unclear. These agents decrease serum concentrations of vitamin BI2,pyridoxal Sphosphate, and folate, all of which are essential for the metabolism of the atherogenic amnio acid homocysteine. We found serum vitamin BIZconcentrations to be lower in 17 women using oral contraceptives (219334 pmol I-') than in 13 age-matched female controls (385k 129, p
ISSN: 0036-5513 (Print) 1502-7686 (Online) Journal homepage: http://www.tandfonline.com/loi/iclb20
Plasma homocysteine in women on oral oestrogen-containing contraceptives and in men with oestrogen-treated prostatic carcinoma L. Brattström, B. Israelsson, A. Olsson, A. Andersson & B. Hultberg To cite this article: L. Brattström, B. Israelsson, A. Olsson, A. Andersson & B. Hultberg (1992) Plasma homocysteine in women on oral oestrogen-containing contraceptives and in men with oestrogen-treated prostatic carcinoma, Scandinavian Journal of Clinical and Laboratory Investigation, 52:4, 283-287, DOI: 10.1080/00365519209088360 To link to this article: http://dx.doi.org/10.1080/00365519209088360
Published online: 29 Mar 2011.
Submit your article to this journal
Article views: 10
View related articles
Citing articles: 3 View citing articles
Full Terms & Conditions of access and use can be found at http://www.tandfonline.com/action/journalInformation?journalCode=iclb20 Download by: [RMIT University Library]
Date: 15 March 2016, At: 19:21
Scand J Clin Lab Invest 1902; 52: 283-287
Plasma homocysteine in women on oral oestrogen-containing contraceptives and in men with oestrogen-treated prostatic carcinoma L . BRATTSTROM,* B. ISRAELSSON,t A. OLSSON,$ A . ANDERSSONB & B. HULTBERGli
Downloaded by [RMIT University Library] at 19:21 15 March 2016
University of Lund, Departments of 'Neurology, tUrology, and $Clinical Chemistry4, University Hospital, Lund, and the ?Department of Medicine, Malmo General Hospital, Sweden.
Brattstrom L, lsraelsson B, Olsson A, Anderson A, Hultberg B. Plasma homocysteine in women on oral oestrogen-containing contraceptives and in men with oestrogen-treated prostatic carcinoma. Scand J Clin Lab Invest 1992; 52: 283-287. The mechanism by which oral oestrogen-containing contraceptives in women and oestrogen treatment of prostatic carcinoma in men increases the risk of vascular disease is unclear. These agents decrease serum concentrations of vitamin BI2,pyridoxal Sphosphate, and folate, all of which are essential for the metabolism of the atherogenic amnio acid homocysteine. We found serum vitamin BIZconcentrations to be lower in 17 women using oral contraceptives (219334 pmol I-') than in 13 age-matched female controls (385k 129, p
